Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 20/20 | 0.50 |
| ▸ | ITGA4 | P13612 | 20/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4734298 | 0.90 | ITGB1 (0.48) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL4737050 | 0.88 | ITGB1 (0.64) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL4734794 | 0.86 | ITGB1 (0.48) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL4736529 | 0.79 | ITGB1 (0.63) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL4736948 | 0.79 | ITGB1 (0.64) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL4732353 | 0.77 | ITGB1 (0.64) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL4736512 | 0.77 | ITGB1 (0.67) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL4735574 | 0.77 | ITGB1 (0.63) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL4735378 | 0.77 | ITGB1 (0.66) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL4737637 | 0.77 | ITGB1 (0.42) | ITGB1ITGA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008064830-A1 | BICYCLIC AND HETEROBICYCLIC DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR PHARMACEUTICAL USES | UCB PHARMA, S.A. (BE) | 2008-06-05 | — | — | WO | claimed |
| WO-2008064830-A1 | BICYCLIC AND HETEROBICYCLIC DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR PHARMACEUTICAL USES | UCB PHARMA, S.A. (BE) | 2008-06-05 | — | — | WO | disclosed |